Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
HYUNDAI PHARMACEUTICAL CO., LTD.
🇰🇷
South Korea
Country
🇰🇷
South Korea
Ownership
Public
Established
1965-01-01
Employees
501
Market Cap
-
Website
http://www.hyundaipharm.co.kr
Clinical Trials
Related News
Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers
Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Surfolase capsule
Drug: HT-002-01
Subscribe
First Posted Date
2012-11-08
Last Posted Date
2012-11-08
Lead Sponsor
Hyundai Pharmaceutical Co., LTD.
Target Recruit Count
24
Registration Number
NCT01723891
Locations
🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy